Clinical Potential of Minocycline for Schizophrenia

E-ISSN： 1996-3181|7|4|376-381

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.7, Iss.4, 2008-10, pp. : 376-381

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Minocycline: Therapeutic Potential in Psychiatry

By Dean Olivia M. Data-Franco João Giorlando Francesco Berk Michael

CNS Drugs, Vol. 26, Iss. 5, 2012-05 ,pp. : 391-401

Adis International

Access to resources Recommend Favorite

Clinical Potential of Omega-3 Fatty Acids in the Treatment of Schizophrenia

By Emsley R.

CNS Drugs, Vol. 17, Iss. 15, 2003-01 ,pp. : 1081-1091

Adis International

Access to resources Recommend Favorite

GABA B Receptors, Schizophrenia and Sleep Dysfunction: A Review of the Relationship and its Potential Clinical and Therapeutic Implications

By Kantrowitz Joshua Citrome Leslie Javitt Daniel

CNS Drugs, Vol. 23, Iss. 8, 2009-08 ,pp. : 681-691

Adis International

Access to resources Recommend Favorite

Potential therapeutic targets for schizophrenia

By Wong A.H. Sanyal S. Knapp M.G. van Tol H.H.

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 4, 1999-12 ,pp. : 571-586

Informa Healthcare

Access to resources Recommend Favorite

Neurotensin Agonists: Potential in the Treatment of Schizophrenia

By Boules Mona

CNS Drugs, Vol. 21, Iss. 1, 2007-01 ,pp. : 13-23

Adis International

Access to resources Recommend Favorite